Literature DB >> 20691961

Escorts take the lead molecular chaperones as therapeutic targets.

Dumaine Williams1, Lakshmi A Devi.   

Abstract

The functional and physiological diversity of transmembrane receptors results from factors that influence the pharmacology, signaling, and trafficking of these receptors. Receptor mutations and other modifications may lead to misfolding, intracellular retention, and ineffective signaling of transmembrane receptors. The importance of such mutations is highlighted by the fact that various diseases have been linked to mutations that lead to ineffective signaling of these receptors, resulting from the retention of receptors in intracellular compartments. Studies focused on understanding the regulation of trafficking and cell surface expression of newly synthesized receptors have highlighted molecular chaperones as key regulators of receptor maturation and sorting. In this chapter, we discuss the functions of molecular chaperones in the regulation of seven-transmembrane-containing G-protein-coupled receptor function and trafficking and explore ways in which chaperones can serve as novel therapeutic targets. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691961      PMCID: PMC3125676          DOI: 10.1016/S1877-1173(10)91005-3

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  114 in total

Review 1.  Oligomerization of G-protein-coupled transmitter receptors.

Authors:  M Bouvier
Journal:  Nat Rev Neurosci       Date:  2001-04       Impact factor: 34.870

2.  Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy.

Authors:  V Heiser; E Scherzinger; A Boeddrich; E Nordhoff; R Lurz; N Schugardt; H Lehrach; E E Wanker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  Heterodimerization of mu and delta opioid receptors: A role in opiate synergy.

Authors:  I Gomes; B A Jordan; A Gupta; N Trapaidze; V Nagy; L A Devi
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

4.  A trafficking checkpoint controls GABA(B) receptor heterodimerization.

Authors:  M Margeta-Mitrovic; Y N Jan; L Y Jan
Journal:  Neuron       Date:  2000-07       Impact factor: 17.173

Review 5.  Melanocortin receptors: their functions and regulation by physiological agonists and antagonists.

Authors:  Z A Abdel-Malek
Journal:  Cell Mol Life Sci       Date:  2001-03       Impact factor: 9.261

Review 6.  RAMPs: The past, present and future.

Authors:  Narayanan Parameswaran; William S Spielman
Journal:  Trends Biochem Sci       Date:  2006-09-28       Impact factor: 13.807

7.  Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor.

Authors:  U E Petaja-Repo; M Hogue; A Laperriere; P Walker; M Bouvier
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

8.  Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell.

Authors:  S P Lee; B F O'Dowd; G Y Ng; G Varghese; H Akil; A Mansour; T Nguyen; S R George
Journal:  Mol Pharmacol       Date:  2000-07       Impact factor: 4.436

9.  Rab1 interaction with a GM130 effector complex regulates COPII vesicle cis--Golgi tethering.

Authors:  B D Moyer; B B Allan; W E Balch
Journal:  Traffic       Date:  2001-04       Impact factor: 6.215

10.  Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation.

Authors:  B A Jordan; N Trapaidze; I Gomes; R Nivarthi; L A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more
  5 in total

1.  Molecular determinants of the human α2C-adrenergic receptor temperature-sensitive intracellular traffic.

Authors:  Catalin M Filipeanu; Ashok K Pullikuth; Jessie J Guidry
Journal:  Mol Pharmacol       Date:  2015-02-13       Impact factor: 4.436

Review 2.  Opioid receptor heteromers in analgesia.

Authors:  Cristina M Costantino; Ivone Gomes; Steven D Stockton; Maribel P Lim; Lakshmi A Devi
Journal:  Expert Rev Mol Med       Date:  2012-04-10       Impact factor: 5.600

3.  Homodimerization as a molecular switch between low and high efficiency PrP C cell surface delivery and neuroprotective activity.

Authors:  Maxime Béland; Xavier Roucou
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

4.  PRR repeats in the intracellular domain of KISS1R are important for its export to cell membrane.

Authors:  Lucie Chevrier; Alexandre de Brevern; Eva Hernandez; Jérome Leprince; Hubert Vaudry; Anne Marie Guedj; Nicolas de Roux
Journal:  Mol Endocrinol       Date:  2013-04-22

5.  Regulation of an Opioid Receptor Chaperone Protein, RTP4, by Morphine.

Authors:  Wakako Fujita; Mini Yokote; Ivone Gomes; Achla Gupta; Hiroshi Ueda; Lakshmi A Devi
Journal:  Mol Pharmacol       Date:  2018-10-22       Impact factor: 4.436

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.